Clal Biotech streams NIS 15.7m to D Pharm
D-Pharm will use the proceeds to promote clinical trials of its stroke and migraine treatments.
View ArticleTeva, Clal Biotech cos team on wound treatments
Polyheal and MediWound are targeting a $9 billion global market for wound treatments.
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Mazor obtains SpineAssist EU CE Mark for brain surgery
Mazor plans to expand use of the SpineAssist system to brain surgery, including treatments to alleviate symptoms of Parkinson’s disease.
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
Image may be NSFW.
Clik here to view.
Clik here to view.
TAU discovers better model to find MS cure
Scientists use mice with type 1 diabetes that actually develop MS; breakthrough could lead to better treatments.
View Article
